美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Golden Eagle Dynamic Hypergrowth ETF

24.95

+0.63002.59%

成交量：676.00

成交额：1.69万

市值：2,819.35万

市盈率：- -

高：25.39

开：25.39

低：24.95

收：24.32

52周最高：28.67

52周最低：21.06

股本：113.00万

流通股本：113.00万

量比：0.27

换手率：0.06%

股息：0.03

股息率：0.13%

净资产收益率：--

总资产收益率：--

市净率：--

市盈率(LYR):- -

数据加载中...

总览公司新闻资讯公告

麻吉今晚持续加仓 ETH 和 HYPE 多单，新多头仓位价值已近 500 万美元

数据：麻吉加仓 HYPE 和 ETH 多单，目前浮盈 20 万美元

汇宇制药(688553.SH)：HYP-6589片联合用药获得药物临床试验申请受理

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/HYP/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"HYP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HYP\",,,,,undefined,":{"symbol":"HYP","market":"US","secType":"STK","nameCN":"Golden Eagle Dynamic Hypergrowth ETF","latestPrice":24.95,"timestamp":1774296000000,"preClose":24.32,"halted":0,"volume":676,"delay":0,"changeRate":0.025904605263157854,"floatShares":1130000,"shares":1130000,"eps":0,"marketStatus":"盘前交易","change":0.63,"latestTime":"03-24 05:04:42 EDT","open":25.39,"high":25.39,"low":24.95,"amount":16943.0802,"amplitude":0.018092,"askPrice":39.67,"askSize":100,"bidPrice":10.04,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1774359000000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":24.95,"sharesOutstanding":1050000,"nav":24.3603,"aum":27527153.75,"dividendRate":0.001267,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":24.95,"preClose":24.95,"latestTime":"18:49 EDT","volume":47,"amount":1172.65,"timestamp":1774306147866,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.2657222276553486},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HYP\",,,,,undefined,":{"symbol":"HYP","floatShares":1130000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.2657222276553486,"shares":1130000,"dividePrice":0.0316,"high":25.39,"amplitude":0.018092,"preClose":24.32,"low":24.95,"week52Low":21.06,"pbRate":"--","week52High":28.67,"institutionHeld":0,"latestPrice":24.95,"eps":0,"divideRate":0.001267,"volume":676,"delay":0,"ttmEps":0,"open":25.39,"prevYearClose":23.4566,"prevWeekClose":24.32,"prevMonthClose":27.4133,"prevQuarterClose":23.4566,"fiveDayClose":25.41,"twentyDayClose":26.9833,"sixtyDayClose":24.4184},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/HYP\",params:#limit:5,,,undefined,":[{"date":"2025-12-24","symbol":"HYP","amount":0.031908,"announcedDate":"2025-12-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-24","defaultRemindTime":1766586600000,"name":"Golden Eagle Dynamic Hypergrowth ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-24","currency":"USD","dateTimestamp":1766552400000,"payDate":"2025-12-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"HYP\",market:\"US\",,,undefined,":[{"executeDate":"2025-12-24","recordDate":"2025-12-24","paymentDate":"2025-12-26","value":0.031908,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"HYP\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"HYP\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2607047553","title":"麻吉今晚持续加仓 ETH 和 HYPE 多单，新多头仓位价值已近 500 万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2607047553","media":"BitPush","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607047553?lang=zh_cn&edition=fundamental","pubTime":"2026-01-30 23:37","pubTimestamp":1769787426,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.bitpush.news//articles/7607433","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"bit_push_live","symbols":["ETH.USD.CC","HYP","BK4601"],"gpt_icon":0},{"id":"2606736778","title":"数据：麻吉加仓 HYPE 和 ETH 多单，目前浮盈 20 万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2606736778","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606736778?lang=zh_cn&edition=fundamental","pubTime":"2026-01-27 23:45","pubTimestamp":1769528705,"startTime":"0","endTime":"0","summary":" ChainCatcher 消息，据 Hyperinsight 监测，麻吉加仓 HYPE 和 ETH 多单，其累计持有价值超 1,182 万美元 ETH 和 HYPE 多单，浮盈 20 万美元。其中：· 持有 3,000 枚 ETH 多单（876 万美元）；· 持有 109,888.88 枚 HYPE 多单（304 万美元）。 ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2240927","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4601","ETH.USD.CC","HYP"],"gpt_icon":0},{"id":"2585155681","title":"汇宇制药(688553.SH)：HYP-6589片联合用药获得药物临床试验申请受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2585155681","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585155681?lang=zh_cn&edition=fundamental","pubTime":"2025-11-21 17:00","pubTimestamp":1763715628,"startTime":"0","endTime":"0","summary":"智通财经APP讯，汇宇制药 发布公告，公司全资子公司四川汇宇海玥医药科技有限公司于2025年11月21日收到国家药品监督管理局核准签发的《受理通知书》，HYP-6589片用于开展与奥希替尼联合治疗靶点驱动基因阳性的晚期非小细胞肺癌的临床试验申请获得受理。HYP-6589片是公司全资子公司汇宇海玥开发的高选择性SOS1小分子抑制剂，其注册分类为化学药1类创新药。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1372089.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","688553","HYP"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":3,"code":"91000000","status":"200"}]}}